[EN] INHIBITORS OF MUTANT FORMS OF EGFR<br/>[FR] INHIBITEURS DE FORMES MUTANTES DE L'EGFR
申请人:BLUEPRINT MEDICINES CORP
公开号:WO2021133809A1
公开(公告)日:2021-07-01
The present disclosure provides a compound represented by structural formula (I) : or a pharmaceutically acceptable salt thereof useful for treating a cancer.
本公开提供了一种由结构公式(I)表示的化合物:或其药用可接受的盐,用于治疗癌症。